Motion Sickness Clinical Trials 2023

Browse 8 Motion Sickness Medical Studies Across 6 Cities
3 Phase 3 Trial · 9 Motion Sickness Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Motion Sickness Clinical Trials 2023

Reviewed by Michael Gill, B. Sc.

Image of Santa Monica Clinical Trials in Santa Monica, United States.

Tradipitantfor Motion Sickness

Santa Monica, CA

A multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy of tradipitant in the treatment of motion sickness.

Santa Monica Clinical TrialsVanda Pharmaceuticals

Image of NASA Johnson Space Center Neuroscience Laboratory in Houston, United States.

DPI-386 Nasal Gelfor Motion Sickness

This trial will evaluate a nasal gel and sensory belt to reduce motion sickness and improve sensorimotor performance. The gel is a safe, non-invasive way to self-administer with quick results.

NASA Johnson Space Center Neuroscience LaboratoryScott J Wood, PhDRepurposed Therapeutics, Inc.

Image of NASA Johnson Space Center Neuroscience Laboratory in Houston, United States.

DPI-386 Nasal Gelfor Motion Sickness

This trial will test the feasibility & efficacy of administering intranasal scopolamine gel to astronauts & ground-controls exposed to motion simulations to prevent/treat motion sickness. Participants complete short questionnaires & discuss countermeasures used & effectiveness.

NASA Johnson Space Center Neuroscience LaboratoryScott J Wood, PhDRepurposed Therapeutics, Inc.

Image of Johns Hopkins University in Baltimore, United States.

SWAN VPT JHUfor Motion Sickness

This trial tested a self-help tool to help people who have dizziness from a medical condition recover balance & reduce motion sickness.

Johns Hopkins University (+1 Sites)Matthew Stewart, MD PhD

Image of Dartmouth-Hitchcock Medical Center in Lebanon, United States.

Scopolaminefor Motion Sickness

This trial is testing a nebulizer that goes up the nose to see if it is a better way to give anti-motion sickness medication.

FDA Approved Drug

Dartmouth-Hitchcock Medical CenterJay C Buckey, Ph.D

Image of Santa Monica Clinical Trials in Santa Monica, United States.

Tradipitant High Dosefor Motion Sickness

Santa Monica, CA

This trial will test whether tradipitant is effective in treating motion sickness.

Waitlist Available

Santa Monica Clinical TrialsVanda Pharmaceuticals

Image of NAMRU-D in Dayton, United States.

Transderm Scop®for Motion Sickness

This multi-site Phase 3 clinical trial is a randomized, double-blind, placebo-controlled and open label active-controlled study to identify the safety and efficacy of a repeated-dose regimen of DPI-386 nasal gel (intranasal scopolamine gel) for the prevention and treatment of motion sickness. The study will be conducted aboard Navy fleet or Marine ships undergoing military operations to obtain data in an operationally relevant real world environment.

Waitlist Available

FDA Approved Drug

NAMRU-DDavid HeltonRepurposed Therapeutics, Inc.

Image of Massachusetts Eye and Ear Infirmary in Boston, United States.

Chronic Motion-modulated Stimulationfor Vestibular Disorder

This trial is studying how different vestibular and non-vestibular cues are integrated by the brain when they are perceived as corresponding to a single event.

Waitlist Available

Massachusetts Eye and Ear Infirmary

8 Motion Sickness Clinical Trials Near Me

Top Hospitals for Motion Sickness Clinical Trials

Image of Santa Monica Clinical Trials in California.

Santa Monica Clinical Trials

Santa Monica

2Active Trials

4All Time Trials for Motion Sickness

2020First Motion Sickness Trial

Image of NASA Johnson Space Center Neuroscience Laboratory in Texas.

NASA Johnson Space Center Neuroscience Laboratory

Houston

2Active Trials

2All Time Trials for Motion Sickness

2021First Motion Sickness Trial

Image of Johns Hopkins University in Maryland.

Johns Hopkins University

Baltimore

1Active Trials

1All Time Trials for Motion Sickness

2022First Motion Sickness Trial

Image of Naval Medical Research Unit in Ohio.

Naval Medical Research Unit

Dayton

1Active Trials

2All Time Trials for Motion Sickness

2014First Motion Sickness Trial

Image of Dartmouth-Hitchcock Medical Center in New Hampshire.

Dartmouth-Hitchcock Medical Center

Lebanon

1Active Trials

1All Time Trials for Motion Sickness

2022First Motion Sickness Trial

Top Cities for Motion Sickness Clinical Trials

Image of Santa Monica in California.

Santa Monica

2Active Trials

Santa Monica Clinical TrialsTop Active Site

Image of Houston in Texas.

Houston

2Active Trials

NASA Johnson Space Center Neuroscience LaboratoryTop Active Site

Motion Sickness Clinical Trials by Phase of Trial

N/A Motion Sickness Clinical Trials

2Active Motion Sickness Clinical Trials

2Number of Unique Treatments

2Number of Active Locations

SWAN VPT JHU Chronic Motion-modulated Stimulation

Motion Sickness Clinical Trials by Age Group

18 - 65 Motion Sickness Clinical Trials

2Active Motion Sickness Clinical Trials

Scopolamine Transderm Scop®

Most Recent Motion Sickness Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

Tradipitant for Motion Sickness

6/1/2023

Phase 3

SWAN VPT JHU for Motion Sickness

8/8/2022

N/A

Scopolamine for Motion Sickness

1/24/2022

Phase 1

DPI-386 Nasal Gel for Motion Sickness

1/21/2022

Phase 2

DPI-386 Nasal Gel for Motion Sickness

8/10/2021

Phase 2

Top Treatments for Motion Sickness Clinical Trials

Treatment Name

Active Motion Sickness Clinical Trials

All Time Trials for Motion Sickness

First Recorded Motion Sickness Trial

DPI-386 Nasal Gel

2

6

2018

Tradipitant

1

2

2018

SWAN VPT JHU

1

1

2022

Scopolamine

1

4

2014

Tradipitant High Dose

1

1

2020

Recently Completed Studies with FDA Approved Treatments for Motion Sickness

Treatment

Year

Sponsor

DPI-386 Nasal Gel

2022

Repurposed Therapeutics, Inc.

About The Author

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: August 8th, 2023

References¹ Todd CJ, Schubert MC, Rinaudo CN, Migliaccio AA. Unidirectional Vertical Vestibuloocular Reflex Adaptation in Humans Using 1D and 2D Scenes. Otol Neurotol. 2022 Oct 1;43(9):e1039-e1044. doi: 10.1097/MAO.0000000000003684. Epub 2022 Sep 9. https://pubmed.ncbi.nlm.nih.gov/36075099

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security